Video

Educated Patient® Lung Cancer Summit: March 6, 2021

Author(s):

CURE staff

View the full CURE Educated Patient Lung Cancer Summit on demand.

Related Videos
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with grey hair.
Image of bald man in suit.
Image of woman with dark hair, smiling.
Image of woman with brown hair.
Related Content
Illustration of intestines.
January 29th 2025

Opdivo Plus Yervoy Improves Outcomes in Metastatic Colorectal Cancer Subset

Russ Conroy
The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic colorectal cancer.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
"Palliative care" text.
January 27th 2025

Palliative Care May Improve Quality of Life in Esophageal Cancer

Tim Cortese
End-of-life palliative care consultations may also ease financial strain for patients with esophageal cancer.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Dr. Eric K. Singhi currently serves as an assistant professor in both the Department of General Oncology and the Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, Texas.
January 27th 2025

How Subcutaneous vs IV May Affect Treatment Adherence in Cancer Care

Ryan Scott
Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version for patients with solid tumors.
Illustration of the body.
January 26th 2025

Study Shows Poor Outcomes in BRAF V600E-Mutant Metastatic CRC

Russ Conroy
Synchronous metastases did not affect survival in resected BRAF V600E-mutated metastatic colorectal cancer.